BELANO Medical - The Micro­biotics Company
BELANO Medical
The Micro­biotics Company

Research and development

Belano - Research and Development

We understand bacteria

As a research and develo­pment company, Belano medical AG is a techno­lo­gical leader in the field of modern micro­biotic products and positively acting bacteria.

Starting with probio­ti­cally acting lactic acid bacteria, we have identified and charac­te­rized specific strains and active ingre­dients in intensive research work. Today, these are indus­trially produced and indivi­dually formu­lated and can already be found on the market as finished products.

Our patented micro­biotic active ingre­dients from lactic acid bacteria (Lacto­ba­c­illus) work in two ways:

  • some support the desirable “good” micro­or­ga­nisms - for example, those found on our skin - so that they’re not overgrown by pathogens, the former also displacing the latter from our skin.
  • others act directly against pathogens such as strep­to­cocci, staphy­lo­cocci, or helico­bacter and prevent them from settling on the skin or in the body.
research and development
forschung 2 1
Belano - Research and Development

We research microbiomes and their effects on our health

Billions of bacteria in and on us help us to stay healthy. Knowledge about these tiny “roommates” has grown consi­derably in recent years. One finding is that we need a balanced and high diversity of micro­biomes to fend off germs and to keep our immune system active and strong on our skin and in our intestines.

Dysbiosis, i.e. a shift in the natural balance, is associated with disorders and diseases. For example, when skin suffers from atopic derma­titis, it is overwhelmed with the inflammatory bacterium Staphy­lo­coccus aureus, which only occurs spora­di­cally on healthy skin. Signs of colds are often accom­panied by an increase in the bacterium Strep­to­coccus pyogenes and stomach problems are often caused by the bacterium Helico­bacter pylori.

We have researched these inter­ac­tions between healthy micro­biomes and patho­genic germs, developing “antago­nists” and evaluating them in precli­nical and clinical studies.

By using microbial antago­nists and the gentle and efficient removal of the inflammatory germs, we were able to restore the natural balance in these ecosystems and, as a result, develop a new microbial therapy platform!

Belano - Research and Development

We develop clinically proven solutions

Our research department constantly analyzes micro­biome inter­ac­tions and further develops our products and active ingre­dients in our own labora­tories (S2). Effect spectra are also carried out on behalf of customers. Clinical studies and approval processes are planned and executed with partners.

Our develo­pment department imple­ments indus­trial production with European partners and also offers the develo­pment of customer-specific formulations.

Our active ingre­dients are patent-protected.

forschung 3 1
Scroll to Top